Eui Ho Kim

Lab head

Institut Pasteur Korea

South Korea

Research Interests

Explore related searches

Professors in South Korea Professors in Immunology Immunology professors in South Korea

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Eui Ho Kim is a Lab Head at the Institut Pasteur Korea, South Korea. His research focuses on the mechanisms of immune responses, particularly in the contexts of cancer immunotherapy and vaccine development. Recent publications explore topics such as immune checkpoint blockade, mRNA vaccine reactogenicity, and antiviral responses to influenza. He is also investigating the effects of various immune-related factors on vaccine-induced immunity and overall disease resistance.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (3)

JinAh Lee

Institut Pasteur Korea

SOUTH KOREA

View details

Jae‐Hwan Nam

SOUTH KOREA

View details

Yeong-Geun Lee

Inje University

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Eui Ho Kim

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Knife’s edge: Balancing immunogenicity and reactogenicity in mRNA vaccines

Mechanisms underlying response and resistance to immune checkpoint blockade in cancer immunotherapy.

Correction: Global deletion of optineurin results in altered type I IFN signaling and abnormal bone remodeling in a model of Paget's disease.

Galectin-4 increases the ability of M2 macrophages to enhance antiviral CD4+ T-cell responses.

Anti-influenza A virus activity by Agrimonia pilosa and Galla rhois extract mixture

Immune responses and reactogenicity after ChAdOx1 in individuals with past SARS-CoV-2 infection and those without

Immunogenicity and Durability of Antibody Responses to Homologous and Heterologous Vaccinations with BNT162b2 and ChAdOx1 Vaccines for COVID-19.

In planta Production and Validation of Neuraminidase Derived from Genotype 4 Reassortant Eurasian Avian-like H1N1 Virus as a Vaccine Candidate.

Potent antiviral activity of the extract of Elaeocarpus sylvestris against influenza A virus in vitro and in vivo.

Role of Damage-Associated Molecular Pattern/Cell Death Pathways in Vaccine-Induced Immunity.

Collaborators (3)

JinAh Lee

Jae‐Hwan Nam

Yeong-Geun Lee

Make your next move.